The world’s smallest heart pump, which was developed by an Israeli startup, is now being used in the treatment of two heart patients in New York as part of an FDA-approved study.

The study is the first step to securing approval for the use of Magenta Medical’s Elevate heart pump in the US. It will evaluate the device’s safety and feasibility in providing temporary support during procedures used to open clogged arteries in the heart.

The Elevate pump can support the heart’s activity, and even temporarily replace the organ for several days by opening clogged arteries of cardiac patients, and reducing symptoms such as chest pain and shortness of breath.

Keep reading at

Magenta Medical is a biotechnology company developing miniaturized catheter-mounted axial-flow pumps for heart failure indications. Magenta Medical COO Gilead Moiseyev is a Technion alumnus.